MedTrace Logo

Estrogen Therapy as Prevention in the Progression of Aneurysm (EPPA) Trial

NCT01895881 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2021-01-05

No results posted yet for this study

Summary

This study aims to determine if hormone replacement therapy, given during perimenopause may prevent the progression of saccular cerebral aneurysms.

Conditions

Interventions

DRUG

Estradiol

DRUG

Placebo

Sponsors & Collaborators

  • Rush University Medical Center

    lead OTHER

Principal Investigators

  • Michael Chen, MD · Rush University Medical Center

  • Barbara Soltes, MD · Rush University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
52 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01895881 on ClinicalTrials.gov